Kiniksa Pharmaceuticals (KNSA) Profit Metrics
Price: $23.03
Market Cap: $1.67B
Avg Volume: 594.50K
Market Cap: $1.67B
Avg Volume: 594.50K
Country: BM
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Profit Metrics Summary (Annual)
According to Kiniksa Pharmaceuticals's latest annual financial reports:
- The company has reported a gross profit of 423.24M, indicating the amount earned after deducting the cost of goods sold (COGS) from revenue. The gross profit margin is 100.00%, with a year-over-year growth of 98.02%.
- Kiniksa Pharmaceuticals's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -45.62M. The EBITDA margin stands at -10.78%, showing a growth of -99.59% compared to the previous year.
- The operating income, representing the profit from business operations before taxes and interest, stands at -45.62M. The operating margin is -10.78%, with a year-over-year growth of -81.04%.
- The net income, which shows the company's total earnings or profit after all expenses, is -43.19M. The net profit margin is -10.21%, demonstrating a growth of -406.68% from the previous year.
These metrics provide a comprehensive overview of Kiniksa Pharmaceuticals's profitability and operational efficiency over the past year.
Gross Profit
$423.24M
Gross Profit Margin (2023)
100.00%
EBITDA
$-45.62M
EBITDA Margin
-10.78%
Operating Income (2023)
$-45.62M
Operating Margin
-10.78%
Net Income
$-43.19M
Net Profit Margin
-10.21%
Historical Gross Profit
Historical Gross Profit Margin
Historical Gross Profit Growth
Historical EBITDA
Historical EBITDA Margin
Historical EBITDA Growth
Historical Operating Income
Historical Operating Profit Margin
Historical Operating Income Growth
Historical Net Income
Historical Net Profit Margin
Historical Net Income Growth
Kiniksa Pharmaceuticals Historical Profit Metrics
Kiniksa Pharmaceuticals Historical Profits
The table below shows various profit metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | Gross Profit | Gross Profit Growth | Operating Income | Operating Income Growth | Net Income | Net Income Growth | EBITDA | EBITDA Growth |
|---|---|---|---|---|---|---|---|---|
| 2024 | $423.24M | 98.02% | $-45.62M | -81.04% | $-43.19M | -406.68% | $-45.62M | -99.59% |
| 2023 | $213.74M | 23.39% | $-25.20M | -441.83% | $14.08M | -92.32% | $-22.86M | -333.86% |
| 2022 | $173.21M | 488.28% | $7.37M | 104.71% | $183.36M | 216.11% | $9.77M | 106.33% |
| 2021 | $29.44M | 873.82% | $-156.64M | 0.46% | $-157.92M | 2.14% | $-154.28M | -1.22% |
| 2020 | $-3.81M | -16.04% | $-157.36M | 7.41% | $-161.38M | 0.30% | $-152.42M | 9.21% |
| 2019 | $-3.28M | -1046.50% | $-169.96M | -57.14% | $-161.87M | -56.81% | $-167.90M | -55.64% |
| 2018 | $-286.00K | -921.43% | $-108.16M | -65.38% | $-103.23M | -59.12% | $-107.87M | -65.02% |
| 2017 | $-28.00K | -27.27% | $-65.40M | -172.48% | $-64.87M | -170.61% | $-65.37M | -172.61% |
| 2016 | $-22.00K | 0.00% | $-24.00M | 0.00% | $-23.97M | 0.00% | $-23.98M | 0.00% |
Related Metrics
Explore detailed financial metrics and analysis for KNSA.